Christoph Geserick

Christoph Geserick is a business development executive with over 25 years of experience in Big Pharma. Currently serving as Senior Director at Bayer Pharmaceuticals, they are responsible for licensing deals and collaborations in Gene Therapy, Ophthalmology, and Cardiovascular sectors. Previously, Christoph held various leadership roles at Bayer, including Director of Early Licensing and Director of Innovation Management in China. They also have experience as a Director at Schering and as a Research Scientist at CNIO, National Cancer Center Spain. Christoph’s academic background includes a Diplom in Biology from the University of Tuebingen and a Ph.D. in Biochemistry from Freie Universität Berlin.